ALZN – alzamend neuro, inc. (US:NASDAQ)
Stock Stats
News
Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo [Yahoo! Finance]
Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo
Alzamend Neuro, Inc. (NASDAQ: ALZN) had its price target lowered by analysts at Ascendiant Capital Markets from $35.00 to $32.00. They now have a "buy" rating on the stock.
Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs [Yahoo! Finance]
Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs
Form 8-K Alzamend Neuro, Inc. For: Dec 12
Form 10-Q Alzamend Neuro, Inc. For: Oct 31
Form 8-K Alzamend Neuro, Inc. For: Oct 15
Form 424B5 Alzamend Neuro, Inc.
Form 8-K Alzamend Neuro, Inc. For: Oct 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.